PR Newswire
PR Newswire EN プレスリリース
PR Newswire が配信する英語プレスリリースの一覧です。
-
PR NewswireENIT・テクノロジー
Why AI Needs More Than Models: Inside CLOE's Human Perception Architecture
Iyuno
-
PR NewswireENIT・テクノロジー
Robo.ai Inc. Reports More Than US$180 Million in Revenue for June-August Period
Robo.ai Inc.
-
PR NewswireEN金融・保険
FAGE ANNOUNCES MULTI-YEAR PARTNERSHIP WITH THE FIA WORLD ENDURANCE CHAMPIONSHIP LONE STAR LE MANS RACE
FAGE International
-
PR NewswireEN医療・健康・介護
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
Alteogen Inc.
-
PR NewswireEN運輸・物流
CSTS Enterprises Proudly Announces Selina Zhou's Promotion to General Manager Following the Historic World Cup Sales Record
CSTS Enterprises
-
PR NewswireEN飲食・食品
The Ritz-Carlton, Bali Introduces Bejana by Petty Elliott, Honouring Indonesia's Culinary Heritage Through a New Chapter
The Ritz-Carlton, Bali
-
PR NewswireEN医療・健康・介護
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
NovaGo Therapeutics
-
PR NewswireENIT・テクノロジー
Trip.com Group Limited to Report Second Quarter and First Half of 2026 Financial Results on September 15, 2026 U.S. Time
Trip.com Group Limited
-
PR NewswireEN金融・保険
KuCoin Web3 Wallet Advances Onchain Execution with Expanded Swap Routes and Limit Orders
KuCoin
-
PR NewswireENIT・テクノロジー
Acer Introduces Veriton RI110 AI Mini Workstation for Powering Hybrid Agentic AI Workloads
Acer
-
PR NewswireENIT・テクノロジー
HK-Listed Macau Firm Asia Pioneer Entertainment (8400.HK) H1 Profit Surges 90-Fold Targets Overseas Expansion for Future Growth
Asia Pioneer Entertainment Holdings Limited
-
PR NewswireENIT・テクノロジー
MEGA SHOW Hong Kong 2026:The Leading Asian Sourcing Event in Hong Kong Returns for its 33rd Edition This October
COMASIA LIMITED
-
PR NewswireENIT・テクノロジー
OceanBase Named Top Distributed Transactional Database Vendor in Asia & Oceania in Omdia Report
OceanBase
-
PR NewswireEN医療・健康・介護
Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC
Norroy Bioscience Co., Ltd.
